The market is overextended. The Nasdaq is running above the top Bollinger Band. Total market cap-to-GDP has never been higher. IPOs are running hot, mergers are gangbusters, and speculation is...
Precious metals have been one of the top-performing asset classes amid the coronavirus pandemic. But there's one metal that has gone gangbusters throughout the crisis, with prices rocketing...
Crude prices rose across the board on Thursday and are in the green by roughly a quarter-percent leading into today’s open. But this is just the beginning of a much larger run-up. These are the...
This is easily the most revolutionary thing Energy and Capital editor Jeff Siegel has ever seen in any energy market. As a trader, he's seen it all, but even he is a little shocked by how much...
There are catalysts lined up for 2021 that will inevitably push oil prices higher… and nothing OPEC+ says or does can slow this momentum. Energy and Capital editor Keith Kohl takes a closer look...
Emerging-market stocks are cheaper now than at any other time going back to the mid-1960s. Energy and Capital editor Christian DeHaemer discusses why emerging markets are the buy of a generation and...
The mainstream financial media mostly credited the Dow's first venture over 30,000 to vaccine optimism. Energy and Capital editor Luke Burgess makes the case for why that's accurate and why he...
There are a ton of headwinds afflicting the oil market today. Despite this, Energy and Capital editor Sean McCloskey expects crude prices to hit $60 a barrel, and soon. Today he reveals why...
Elon Musk wants to send settlers to colonize Mars.
A climate-friendly president is heading to Washington, and it’s hard not to be bullish on clean energy. Energy and Capital editor Keith Kohl reminds investors not to sleep on the fastest-growing...
Solar is taking off, and demand from corporations is up huge. Energy and Capital editor Christian DeHaemer explains how investors can take advantage of a rising solar market...
There have been three Monday mornings in a row a major pharmaceutical company announced a coronavirus vaccine with a high efficacy rate. Something seems fishy about the timing of these...